Vismodegib

Vismodegib, also known as GDC-0449 or RG3616, is a hedgehog antagonist, is also a n orally bioavailable small molecule with potential antineoplastic activity. Hedgehog antagonist GDC-0449 targets the Hedgehog signaling pathway, blocking the activities of the Hedgehog-ligand cell surface receptors PTCH and/or SMO and suppressing Hedgehog signaling.
Supplier Alfa Cytology
Product # BC0367
Pricing 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0g, 2.0g, 5.0 g, inquire
Feedback